SARS‐CoV‐2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway
mLife · 2026-10 · 5 (5) · 597-610
DOI: 10.1002/mlf2.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift mLife, online erschienen am 26.10.2026. Verfasst von Lihong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou National Laboratory Guangzhou China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The innate immune system functions as the frontline barrier against invading pathogens, such as severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Nevertheless, the virus has developed various strategies to effectively regulate host immune responses, particularly through the inhibition of interferon signaling. In this study, we identify the SARS‐CoV‐2 accessory protein ORF6 as a key inhibitor of interferon gamma (IFNγ) signaling through downregulation of the interferon‐induced 35‐kDa protein (IFP35). IFP35 , an interferon‐stimulated gene (ISG) critical for interferon ‐mediated antiviral response, is significantly upregulated during SARS‐CoV‐2 infection. Silencing IFP35 via RNA interference enhances viral replication, indicating its antiviral role. Furthermore, we demonstrate that ORF6 associates with IFP35 and accelerates its ubiquitin–proteasome degradation, thereby impairing IFP35's ability to activate IFNγ signaling. These data reveal novel mechanisms used by SARS‐CoV‐2 to circumvent host immunity, specifically by impairing IFNγ signaling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guangzhou National Laboratory Guangzhou China.
- Centre for Infection and Immunity Studies (CIIS), School of Medicine Shenzhen Campus of Sun Yat-sen University Shenzhen China.
- Guizhou University of Traditional Chinese Medicine Guiyang China.
ORCID-Profile: Lihong Liu, Sidi Yang, Chunmei Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, L., Du, J., Huang, J., Yang, S., Xiao, Q., Cao, L., Peng, H., Zheng, B., Li, C., & Guo, D. (2026). SARS‐CoV‐2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. mLife, 5(5), 597-610. https://doi.org/10.1002/mlf2.70112
Vancouver
Liu L, Du J, Huang J, Yang S, Xiao Q, Cao L, et al. SARS‐CoV‐2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway. mLife. 2026;5(5):597-610. doi:10.1002/mlf2.70112
BibTeX
@article{Liu2026,
author = {Liu, Lihong and Du, Jie and Huang, Jiacheng and Yang, Sidi and Xiao, Qiaoqiao and Cao, Liu and Peng, Hong and Zheng, Birong and Li, Chunmei and Guo, Deyin},
title = {SARS‐CoV‐2 ORF6 protein targets IFP35 to inhibit the IFNγ signaling pathway},
journal = {mLife},
year = {2026},
volume = {5},
number = {5},
pages = {597--610},
doi = {10.1002/mlf2.70112}
}
EUVIMED